Similar risk of hospitalization and mortality for patients continuing and discontinuing LTOT
In this study, patients fulfilling LTOT initiation criteria who discontinued therapy were not found to be at an increased risk of hospitalization or death, suggesting equipoise for a randomized trial of LTOT discontinuation or non-initiation in selected patient groups.
Authors
- Filip Björklund (ORCID: https://orcid.org/0000-0002-5199-3570)
- Magnus Per Ekström (ORCID: https://orcid.org/0000-0002-7227-5113)
- Yet Hong Khor (ORCID: https://orcid.org/0000-0002-5434-9342)
- Andreas Palm (ORCID: https://orcid.org/0000-0002-0590-0417)
- Josefin Sundh (ORCID: https://orcid.org/0000-0003-1926-8464)
Institutions
- Uppsala University (SE)
- Uppsala University Hospital (SE)
- The University of Melbourne (AU)
- Lund University (SE)
- Örebro University (SE)
- Institute for Breathing and Sleep (AU)
- Austin Health (AU)
- Monash University (AU)
Publication Details
- Journal
- Respiratory Research
- Published
- 2025-11-15
- DOI
- https://doi.org/10.1186/s12931-025-03417-0
- Primary Topic
- Pituitary Gland Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00